Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml while breastfeeding. We will also discuss about common side effects and warnings associated with Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml.

What is Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml used for?


Sulfacetamide Sodium and Prednisolone Sodium Phosphate Ophthalmic Solution is indicated for corticosteroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. Ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns or penetration of foreign bodies. The use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The particular anti-infective drug in this product is active against the following common bacterial eye pathogens: Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species, and Enterobacter species. This product does not provide adequate coverage against: Neisseria species, Serratia marcescens. A significant percentage of staphylococcal isolates are completely resistant to sulfa drugs.

Can I continue breastfeeding if I am using Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml? How long does it stays in breast milk?

Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml safe for breastfeeding
Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml is primarily made of two things Sulfacetamide sodium, Prednisolone 21-phosphate. What we have done here is we have analyzed Sulfacetamide sodium for its impact on breastfeeding and analyzed Prednisolone 21-phosphate for its impact on breastfeeding. Our analysis of Sulfacetamide sodium and Prednisolone 21-phosphate suggests that Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml is probably safe in breastfeeding however we suggest you to check detail about both below.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk. Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. Systemically administered sulfonamides are capable of producing kernicterus in infants of lactating women. Because of the potential for serious adverse reactions in nursing infants from sulfacetamide sodium and prednisolone sodium phosphate ophthalmic solution, a decision should be made whether to discontinue nursing or to discontinue the medication.

Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml Breastfeeding Analsys


Sulfacetamide sodium while Breastfeeding

Safe

CAS Number: 144-80-9

A short-term action Sulfonamide which is similar to Sulfathiazole (see specific info) that is locally used on vagina, eyes and skin. At latest update relevant published data were not found on excretion into breast milk. Because of the small dose used and poor absorption into plasma of most topical preparations for dermatological and ophthalmological issues, it is unlikely a significant excretion into breast milk. As with other sulfonamides, caution is recommended when using it on preterm infants and newborns with hyperbilirubinemia. Avoid it on patients affected with deficit of Glucose 6-Phosphate Dehydrogenase (6-GPD). Monitor the appearance of jaundice in the infant.

Prednisolone 21-phosphate while Breastfeeding

Safe

CAS Number: 50-24-8

Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml and breastfeeding

Excreted into breast milk in non-significant amount with no problems reported in breastfed infants whose mothers were treated at a daily dose as high as 7.5 mg for a long time period. At a daily dose of 60 mg used for treatment of Herpes or Gestational Pemphigus no harm effects on breastfed infants have been reported. On long term treatments it would be advisable to wait for 3 - 4 hours until the next nurse to minimize the transfer of drug to breast milk. At high doses, intra-articular treatment with other steroid drugs (Triamcinolone) have transiently affected milk production. Steroids administered before delivery may delay initiation of phase II of Lactogenesis ("milk come in") and decrease milk production in the first postpartum week. Decreased production has been seen while taking Dexametasone. Steroid drugs are commonly used for Pediatric treatment with no side effects when infrequently used and for short-time periods. The American Academy of Pediatrics rates it compatible with breastfeeding. WHO Model List of Essential Medicines (2002) rates it compatible with breastfeeding


Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml Breastfeeding Analsys - 2


Prednisolone 21-phosphate while Breastfeeding

CAS Number: 50-24-8

Amounts of prednisolone in breastmilk are very low. No adverse effect have been reported in breastfed infants with maternal use of any corticosteroid during breastfeeding. With high maternal doses, avoiding breastfeeding for 4 hours after a dose should markedly decrease the dose received by the infant. However, this maneuver is not necessary with short-term use. High doses might occasionally cause temporary loss of milk supply. Because absorption from the eye is limited, ophthalmic prednisolone would not be expected to cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.


Is Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml safe while breastfeeding

What should I do if already breastfed my kid after using Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml?

Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.


My health care provider has asked me to use Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml, what to do?

Usage of Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml is safe for nursing mothers and baby, No worries.


If I am using Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Sulfacetamide Sodium And Prednisolone Sodium Phosphate 5 Ml in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week